30.12.2012 Views

The Staphylococcus aureus secretome - TI Pharma

The Staphylococcus aureus secretome - TI Pharma

The Staphylococcus aureus secretome - TI Pharma

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chapter 4<br />

D<br />

O<br />

540<br />

18<br />

16<br />

14<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

0 5 10 15 20 25<br />

Time (h)<br />

SH1000+<br />

SH1000-<br />

secY2+<br />

secY2-<br />

comGA<br />

dsbA<br />

lgt<br />

prsA<br />

Figure 4 Growth properties of mutant S. <strong>aureus</strong> strains and RNAIII production. (A) Growth curves of several<br />

different S. <strong>aureus</strong> SH1000 secretion mutants. Strains were grown in TSB at 37 o C under vigorous shaking and the<br />

OD 540 was measured at hourly intervals. <strong>The</strong> S. <strong>aureus</strong> SH1000+ and ∆secY2+ strains show hemolysin activity on<br />

blood agar plates, while the SH1000- and ∆secY2- strains do not show this feature. (B) RNA was prepared from S.<br />

<strong>aureus</strong> cells grown in TSB to optical densities at 540 nm of 1, 10 or 15. Serial dilutions of total RNA of S. <strong>aureus</strong><br />

RN4220 wild-type (WT) or ∆prsA (left panels), or S. <strong>aureus</strong> SH1000 wild-type (WT) or ∆prsA (right panels) were<br />

blotted and cross linked onto a positively charged nylon membrane. <strong>The</strong> membrane-bound RNA was hybridized<br />

with a digoxigenin labeled RNA probe complementary to RNAIII. Chemiluminescence signals were detected with a<br />

LumiImager (Roche Diagnostics, Mannheim, Germany).<br />

Since the growth to high density coincided with a non-hemolytic phenotype on blood agar<br />

plates, we tested whether these strains might have accumulated agr mutations, leading to the<br />

loss of the regulatory RNAIII. Indeed, dot blot analyses performed for the S. <strong>aureus</strong> SH1000<br />

prsA mutant strain, for which this high density growth phenotype was first observed, revealed<br />

the loss of RNAIII production (Figure 4B). In contrast, the S. <strong>aureus</strong> RN4220 prsA mutant<br />

produced RNAIII at levels comparable to those of the parental strain (Figure 4B).<br />

Figure 5. Agr-like phenotypes of S. <strong>aureus</strong> SH1000-derived secretion mutants. (A) <strong>The</strong> S. <strong>aureus</strong> SH1000<br />

parental strain (WT), an SH1000 ∆cidA strain, an SH1000 ∆comGC strain, an SH1000 ∆dsbA strain, and an<br />

SH1000 ∆prsA strain were grown on blood agar plates and incubated overnight at 37ºC. Hemolytic activity is<br />

detectable as a halo around the streaked cells. (B) S. <strong>aureus</strong> SH1000 (WT), S. <strong>aureus</strong> SH1000 ∆cidA, S. <strong>aureus</strong><br />

SH1000 ∆comC, S. <strong>aureus</strong> SH1000 ∆comGA, S. <strong>aureus</strong> SH1000 ∆comGC, and S. <strong>aureus</strong> SH1000 ∆dsbA were<br />

grown in TSB medium at 37 o C till the early stationary phase. Samples of extracellular proteins isolated from the<br />

growth medium (M), non-covalently cell wall-bound proteins (CW) and total cells (C) were used for Western<br />

blotting and immunodetection with specific antibodies against TrxA or SspB. Note that the antibodies against TrxA<br />

are also bound by the IgG-binding proteins protein A (Spa) and Sbi. Bands corresponding to Spa, Sbi, SspB and<br />

TrxA are marked with arrows.<br />

84

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!